261 related articles for article (PubMed ID: 28240606)
1. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.
Bekerman E; Neveu G; Shulla A; Brannan J; Pu SY; Wang S; Xiao F; Barouch-Bentov R; Bakken RR; Mateo R; Govero J; Nagamine CM; Diamond MS; De Jonghe S; Herdewijn P; Dye JM; Randall G; Einav S
J Clin Invest; 2017 Apr; 127(4):1338-1352. PubMed ID: 28240606
[TBL] [Abstract][Full Text] [Related]
2. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
[TBL] [Abstract][Full Text] [Related]
3. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.
Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S
Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.
Pu SY; Xiao F; Schor S; Bekerman E; Zanini F; Barouch-Bentov R; Nagamine CM; Einav S
Antiviral Res; 2018 Jul; 155():67-75. PubMed ID: 29753658
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
[TBL] [Abstract][Full Text] [Related]
6. Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.
Xiao F; Wang S; Barouch-Bentov R; Neveu G; Pu S; Beer M; Schor S; Kumar S; Nicolaescu V; Lindenbach BD; Randall G; Einav S
mBio; 2018 Mar; 9(2):. PubMed ID: 29535204
[TBL] [Abstract][Full Text] [Related]
7. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P
J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.
Verdonck S; Pu SY; Sorrell FJ; Elkins JM; Froeyen M; Gao LJ; Prugar LI; Dorosky DE; Brannan JM; Barouch-Bentov R; Knapp S; Dye JM; Herdewijn P; Einav S; De Jonghe S
J Med Chem; 2019 Jun; 62(12):5810-5831. PubMed ID: 31136173
[TBL] [Abstract][Full Text] [Related]
9. Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.
Neveu G; Barouch-Bentov R; Ziv-Av A; Gerber D; Jacob Y; Einav S
PLoS Pathog; 2012; 8(8):e1002845. PubMed ID: 22916011
[TBL] [Abstract][Full Text] [Related]
10. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
Karim M; Saul S; Ghita L; Sahoo MK; Ye C; Bhalla N; Lo CW; Jin J; Park JG; Martinez-Gualda B; East MP; Johnson GL; Pinsky BA; Martinez-Sobrido L; Asquith CRM; Narayanan A; De Jonghe S; Einav S
Antiviral Res; 2022 Aug; 204():105367. PubMed ID: 35738348
[TBL] [Abstract][Full Text] [Related]
11. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S
Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888
[TBL] [Abstract][Full Text] [Related]
14. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.
Lupberger J; Zeisel MB; Xiao F; Thumann C; Fofana I; Zona L; Davis C; Mee CJ; Turek M; Gorke S; Royer C; Fischer B; Zahid MN; Lavillette D; Fresquet J; Cosset FL; Rothenberg SM; Pietschmann T; Patel AH; Pessaux P; Doffoël M; Raffelsberger W; Poch O; McKeating JA; Brino L; Baumert TF
Nat Med; 2011 May; 17(5):589-95. PubMed ID: 21516087
[TBL] [Abstract][Full Text] [Related]
15. Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking.
Blaising J; Lévy PL; Polyak SJ; Stanifer M; Boulant S; Pécheur EI
Antiviral Res; 2013 Oct; 100(1):215-9. PubMed ID: 23981392
[TBL] [Abstract][Full Text] [Related]
16. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S
Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase.
Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S
Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682
[TBL] [Abstract][Full Text] [Related]
18. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
[TBL] [Abstract][Full Text] [Related]
19. Development of a broad-spectrum antiviral with activity against Ebola virus.
Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S
Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
